Strong polyclonal activation (PMA/ionomycin) of normal B and T lymphocytes did not induce PRELP expression (data not shown), suggesting that the expression in CLL might reflect a constitutive tumor-related aberration in vivo. Here, PRELP is linked to B-cell chronic lymphocytic leukemia.